SARS-CoV-2 Archives - Drugs in Context

COVID-19 therapy and vaccination: a clinical narrative review

Siddharth Chinta, Miguel Rodriguez-Guerra, Mohammed Shaban, Neelanjana Pandey, Maria Jaquez-Duran, Timothy J Vittorio

Article Type

Review

Published

07 Feb 2023

This review discusses how the SARS-CoV-2 pandemic has progressed and surged, and summarizes the safety and efficacy of the most used therapies and vaccines in the light of recent evidence.

Addressing COVID-19 vaccine hesitancy

George Kassianos, Joan Puig-Barberà, Hannah Dinse, Martin Teufel, Özlem Türeci, Shanti Pather

Article Type

Review

Published

20 Jun 2022

This article seeks to summarize the currently available information to address the most common concerns regarding COVID-19 vaccination.

Vitamins, supplements and COVID-19: a review of currently available evidence

Lauren Speakman, Sarah Michienzi, Melissa Badowski

Article Type

Review

Published

06 Oct 2021

The purpose of this review was to analyse clinical trials regarding vitamins and supplements for the treatment of COVID-19 infections.

Response to ‘Presentation and pathophysiology of neuro-COVID’

Daniele Orsucci, Marco Vista

Article Type

Letter-to-the-Editor

Published

16 Aug 2021

Letter to the Editor in response to Finsterer J, Scorza FA, Scorza CA. Presentation and pathophysiology of neuro-COVID. Drugs Context. 2021;10:2021-6-5

Presentation and pathophysiology of neuro-COVID

Josef Finsterer, Fulvio Alexandre Scorza, Carla Alexandra Scorza

Article Type

Letter-to-the-Editor

Published

12 Aug 2021

Letter to the Editor commenting on Orsucci D, Caldarazzo Ienco E, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: a review. Drugs Context. 2020;9:2020-5-1.